Skip to main content
. 2010 Apr 28;43(3):262–274. doi: 10.1111/j.1365-2184.2010.00673.x

Figure 5.

Figure 5

Expression analyses of cyclin B1 in control and treated KYSE‐510 cells. SDS–PAGE performed 24 h after the end of individual (PDT; CDDP 1 μm) or combined (PDT + CDDP 1 μm) treatments (a). Immunolocalization of cyclin B1 in cells accumulated in S‐ and G2 phases (b).